Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Imidazole | HCID 795 | — |
| Reactant | Methanol | HCID 887 | — |
| Reactant | tert-Butyldimethylsilyl chloride | HCID 28928 | — |
| Reactant | HCID 22243009 | HCID 22243009 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 22242792 | HCID 22242792 | 69% |
Reaction Steps
To a solution of 3-hydroxy-1-{4-[N-(2-hydroxyethyl)-N-isopropyl-carbamoyl]-1,3-thiazol-2-yl}azetidine (1.33 g, 4.66 mmol) (obtained as described in Reference Example 59(2)) in dimethylformamide (40 ml) were added t-butyldimethylsilyl chloride (738 mg, 4.89 mmol) and imidazole (333 mg, 4.89 mmol) in an ice bath, and the mixture was stirred in the ice bath for 2 hours. After checking the completion of the reaction, methanol was added thereto and the mixture was stirred for 30 minutes. After checking the completion of the reaction, the reaction mixture was partitioned between ethyl acetate and saturated aqueous sodium hydrogencarbonate solution. The organic layer was washed with saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by chromatography on a silica gel column using hexane:ethyl acetate (1:1) ethyl acetate as the eluant to afford 1-(4-{N-[2-(t-butyldimethylsilyloxy)-ethyl]-N-isopropyl-carbamoyl}-1,3-thiazol-2-yl)-3-hydroxyazetidine (1.26 g, yield 69%) as a pale yellow oil.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07001897B2 |
|---|
| Source dataset | uspto-grants-2006_02 |
|---|
| ORD ID | ord-5183cf3eb8c14b99a1f7e35791c69b1d |
|---|
| Source note | uspto-grants-2006_02 |
|---|